Cardio Q70/50 has successfully obtained EU-MDR Certification. With the MDR certification of outstanding new products such as the Brio X Series and Cardio Q70/50, we aim to strengthen our presence and enhance our competitiveness across European and global markets.

 

Bionet’s patient monitoring device ‘Brio X Series’ has obtained EU-MDR certification.

‘Cardio P1’ FDA Cleared! Bionet’s PC-based ECG ‘Cardio P1’has received clearance from the US FDA. Recognizing the excellence and technology incorporated into Cardio P1, we aim to enhance our competitiveness in the global ECG market, capitalizing on FDA clearances that underscores its high accuracy and usability.

Bionet has achieved a historic milestone by securing the EU MDR CE Marking for the first wireless handheld ultrasound scanner in South Korea. With this approval to enter the EU market, Bionet aims to actively promote the export of SonoMe products to the European region, thereby enhancing its competitiveness in the global market. Read the full article ▶ https://www.ebionet.com/blog/news/sonome_cemarking

SonoMe is designated as ‘Venture Startup Innovation Procurement Product’ by the ‘Public Procurement Service’. Thanks to its excellent quality and functionalities, ‘Bionet’s wireless hand-held ultrasound scanner ‘SonoMe’, has been designated as a ‘Venture Startup Innovation Procurement Product’ by the ‘Public Procurement Service.’ Bionet will make its entry into the public market sector and accelerate its expansion in both the domestic and global market space. [SonoMe] Wireless Handheld Ultrasound Scanner ✔️ FDA & KFDA approved product quality ✔️ Wireless connection to Smart Devices via Wi-Fi ✔️ Eight varying device line-up for various clinical applications ✔️ High-Definition image and DICOM

Bionet’s ‘Brio X Series’ has been selected by Ministry of Trade, Industry and Energy (MOTIE) as an outstanding R&D Innovative Product, thanks to its User-friendly interface (UI) and specialized functions for each clinical environment. Utilizing our selection of innovative products, we will enter the public markets sector and vitalize our innovative procurement. We also plan to actively navigate ways to expand our overseas market entry. [Brio X Series] Premium Patient Monitors that can be used in emergency rooms and intensive care units. ✔️ KFDA approved ✔️ Myocardial ischemia & damage monitoring system ‘ST Map’ ✔️ Intuitive and simple UX/UI ✔️ High resolution and touchscreen

Finally, Bionet’s ‘ST Map’, an electrocardiogram data display method for myocardial ischemia detection, has been patented. ST Map is installed on Bionet’s major products such as Cardio 7, Cardio Q50/Q70/P1, and Brio X Series, allowing intuitive diagnosis of myocardial ischemia and damage. [ST Map] ✔️ Visual information of ST segment deviation and spatial orientation ✔️ Intuitive and easy understanding of each clinical location of subendocardial ischemia and transmural injury ✔️ More frequent, quick, and accurate monitoring As Bionet increases the technological competitiveness of our products in the global market, it is expected that our products will gain momentum in overseas expansion.